BGI Genomics enhances NIFTY prenatal testing kit with DNBSEQ-G99 platform for faster and accurate results

BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD certification to include the DNBSEQ-G99 model to meet the European Union regulations for medical devices.

Cold plasma is a quantum leap for the treatment of chronic wounds – Biotech Investments

EQS-News: Viromed Medical AG / Key word(s): Study/Study results Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds 06.10.2023 /

October 7, 2023

Insulin is increasingly affordable in the U.S. What about the rest of the world?

In March, Eli Lilly, Novo Nordisk, and Sanofi — the world’s three largest insulin manufacturers — committed to reducing the U.S. list price of insulin,

October 24, 2023

Early Win for Preemptive Stents on Vulnerable Coronary Plaque

ATLANTA — The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first

April 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.